Clinical Trial Update: Mesenchymal Stem Cell Therapy in Multiple System Atrophy [Phase 1, Phase 2]

View source ↗

Summary

A Mayo Clinic-sponsored clinical trial evaluating mesenchymal stem cell therapy for multiple system atrophy is in Phase 1/Phase 2 and is currently active but no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple System Atrophy

Drugs mentioned

• Mesenchymal stem cell therapy (mesenchymal stem cells)

Snippet

Sponsor: Mayo Clinic | Conditions: MSA | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING